High levels of matrix metalloproteinases regulate proliferation and hormone secretion in pituitary cells

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 1, 2000, Pages 263-269

  Pereda, Marcelo Páez ^a   Ledda, M Fernanda ^b   Goldberg, Victoria ^c   Chervín, Alberto ^d   Carrizo, Guillermo ^d   Molina, Hugo ^e   Müller, Adolf ^f   Renner, Ulrich ^a   Podhajcer, Osvaldo ^b   Arzt, Eduardo ^b   Stalla, Günter K ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

^d Hospital Oftalmologico Santa Lucia   (Argentina)

^e HOSPITAL RAMOS MEJÍA   (Argentina)

^f UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT; MATRIX METALLOPROTEINASE;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; DRUG USE; ENZYME ACTIVITY; FEMALE; GROWTH REGULATION; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BLOTTING, NORTHERN; CELL DIVISION; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; PHENYLALANINE; PITUITARY GLAND; PITUITARY HORMONES; PITUITARY NEOPLASMS; PROTEASE INHIBITORS; RATS; THIOPHENES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

EID: 0343006221     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.1.263     Document Type: Article

References (32)

1. The cytogenesis and pathogenesis of pituitary adenomas
2. Interleukin-2 (IL-2) and IL-6 regulate c-fos protooncogene expression in human pituitary adenoma explants
3. Adenomatous transformation of the human anterior pituitary is associated with alterations in integrin expression
4. Fibronectin isoforms are differentially expressed in normal and adenomatous human anterior pituitaries
5. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis
6. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
7. Tumor cell interactions with the extracellular matrix during invasion and metastasis
8. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production
9. Expression of matrix metalloproteinase genes in transformed rat cell lines of high and tow metastatic potential
10. Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression
11. Matrix metalloproteinases and tumor invasion: From correlation and causality to the clinic
12. Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small cell lung carcinoma
13. A matrix metalloproteinase expressed on the surface of invasive tumor cells
14. Dynamics of matrix turnover during pathological remodeling of the extracellular matrix
15. ECM and cell surface proteolysis: Regulating the cellular ecology
16. Changing views of the role of matrix metalloproteinases in metastasis
17. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases
18. MMP-9/Gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
19. Overexpression of metalloproteinase inhibitor in B16FT10 cells does not affect extravasation but reduces tumor growth
20. Generation of biologically active IL-1β by matrix metalloprotemases: A novel caspase-1-independent pathway of IL-1β processing
21. The degradation of human endothelial cell-derived pertecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin and heparanases
22. Interleukin-2 and interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell cultures
23. Interleukin-1β enhances interleukin-1 receptor antagonist content in human somatotroph adenoma cell cultures
24. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells
25. Interleukin involvement in anterior pituitary cell growth regulation: Effects of interteukin-2 and interleukin-6
26. Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer
27. Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines
28. Retinoic acid stimulates meningioma cell adhesion to the extracellutar matrix and inhibits invasion
29. Sequence of human tissue inhibitors of metalloproteinases and its identity to erythroid-potentiating activity
30. Pituitary cytokine and growth factor expression and action
31. Pathophysiological role of the cytokine network in the anterior pituitary gland
32. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin